Finance

Beta
Lists
CU6:ASX
Clarity Pharmaceuticals Ltd
A$2.31
0.00%
(0.00) 1D
Jun 3, 4:10:28 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CU6...
Mkt. cap
861.56M
Avg. vol.
2.27M
Volume
0.00
52-wk high
A$5.87
52-wk low
A$1.97
EPS
-A$0.28
Shares outstanding
372.97M
No. of employees
88
Mkt. cap
861.56M
Avg. vol.
2.27M
Volume
0.00
52-wk high
A$5.87
52-wk low
A$1.97
EPS
-A$0.28
Shares outstanding
372.97M
No. of employees
88
News stories
From sources across the web
About Clarity Pharmaceuticals Ltd
CEO-
Employees88
Founded2010
Headquarters-
SectorPharmaceutical industry
Websiteclaritypharmaceuticals.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.39M
2.39M
2.90M
2.90M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
19.16M
19.16M
25.25M
25.25M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.88M
2.88M
5.98M
5.98M
Operating expense
22.04M
22.04M
31.23M
31.23M
Total operating expenses
22.04M
22.04M
31.23M
31.23M
Operating income
-19.65M
-19.65M
-28.33M
-28.33M
Other non operating income
-
-
-
-
EBT including unusual items
-20.17M
-20.17M
-27.59M
-27.59M
EBT excluding unusual items
-20.17M
-20.17M
-27.59M
-27.59M
Income tax expense
185.23K
185.23K
176.20K
176.20K
Effective tax rate
-0.92%
-0.92%
-0.64%
-0.64%
Other operating expenses
-
-
-
-
Net income
-20.36M
-20.36M
-27.82M
-27.82M
Net profit margin
-852.75%
-852.75%
-958.28%
-958.28%
Earnings per share
-
-
-
-
Interest and investment income
942.16K
942.16K
2.12M
2.12M
Interest expense
-
-
-
-
Net interest expenses
942.16K
942.16K
2.12M
2.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.60M
-19.60M
-28.25M
-28.25M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer